| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
GRCE
Grace Therapeutics
|
Aug 18, 2026 | BUY |
Strong Buy
+151.0% avg upside
9 analysts
|
$4.00
86.98% Upside
|
+0.0% | · |
|
BFLY
Butterfly Network
|
Aug 18, 2026 | BUY |
Strong Buy
-39.0% avg upside
8 analysts
|
$10.00
13.18% Upside
|
· | · |
|
CELC
Celcuity
|
Aug 18, 2026 | BUY |
Strong Buy
+30.8% avg upside
16 analysts
|
$173.00
85.99% Upside
|
+0.0% | · |
|
ACOG
Alpha Cognition Inc
|
Aug 14, 2026 | BUY |
Strong Buy
+100.0% avg upside
4 analysts
|
$17.00
98.16% Upside
|
+0.6% | · |
|
ETON
Eton Pharmaceuticals
|
Aug 14, 2026 | BUY |
Strong Buy
-39.6% avg upside
9 analysts
|
$76.00
22.89% Upside
|
+7.8% | · |
|
XTNT
Xtant Medical Holdings
|
Aug 12, 2026 | BUY |
Strong Buy
+1636.1% avg upside
9 analysts
|
$0.60
81.20% Upside
|
+0.0% | · |
|
FENC
Fennec Pharmaceuticals
|
Aug 12, 2026 | BUY |
Strong Buy
+43.1% avg upside
9 analysts
|
$18.00
50.96% Upside
|
-0.9% | · |
|
CVRX
CVRx
|
Aug 11, 2026 | HOLD |
Buy
+126.9% avg upside
9 analysts
|
— | +18.5% | · |
|
DCTH
Delcath Systems
|
Aug 07, 2026 | BUY |
Strong Buy
+30.3% avg upside
11 analysts
|
$24.00
43.14% Upside
|
+10.7% | · |
|
KRMD
REPRO-MED Systems
|
Aug 06, 2026 | BUY |
Strong Buy
+91.9% avg upside
9 analysts
|
$6.00
80.24% Upside
|
-4.5% | · |
|
BVS
Bioventus
|
Aug 06, 2026 | BUY |
Strong Buy
+4.4% avg upside
8 analysts
|
$18.00
24.61% Upside
|
+2.0% | · |
|
MYO
Myomo
|
Aug 06, 2026 | BUY |
Strong Buy
+340.6% avg upside
9 analysts
|
$1.70
2.79% Upside
|
+31.3% | · |
|
INDV
Indivior
|
Aug 04, 2026 | BUY |
Strong Buy
-5.0% avg upside
10 analysts
|
$53.00
34.92% Upside
|
+7.1% | · |
|
PHAT
Phathom Pharmaceuticals
|
Jul 31, 2026 | BUY |
Strong Buy
+181.8% avg upside
14 analysts
|
$20.00
116.43% Upside
|
+9.5% | · |
|
PYPD
PolyPid
|
Jul 22, 2026 | BUY |
Strong Buy
+233.7% avg upside
7 analysts
|
$12.00
158.01% Upside
|
+18.5% | · |
|
GUTS
Fractyl Health, Inc.
|
Jul 16, 2026 | BUY |
Strong Buy
+550.2% avg upside
7 analysts
|
$4.00
464.49% Upside
|
-20.0% | · |
|
IRWD
Ironwood Pharma
|
Jul 14, 2026 | BUY |
Hold
+176.0% avg upside
23 analysts
|
— | +8.3% | · |
|
HROW
Harrow Health
|
Jul 13, 2026 | BUY |
Strong Buy
+37.9% avg upside
12 analysts
|
$59.00
50.25% Upside
|
-0.4% | · |
|
XERS
Xeris Pharmaceuticals
|
Jul 08, 2026 | BUY |
Strong Buy
+9.8% avg upside
10 analysts
|
$12.00
37.93% Upside
|
-0.8% | · |
|
MDXG
MiMedx Group
|
Jul 06, 2026 | BUY |
Strong Buy
+146.8% avg upside
17 analysts
|
— | +5.2% | · |
|
WEST
Westrock Coffee
|
Jul 01, 2026 | BUY |
Strong Buy
+19.7% avg upside
8 analysts
|
— | +11.8% | · |
|
MAMA
Mama's Creations
|
Jun 30, 2026 | BUY |
Strong Buy
+44.2% avg upside
9 analysts
|
— | -9.3% | · |
|
DMAC
Diamedica Therapeutics
|
Jun 24, 2026 | BUY |
Strong Buy
+125.3% avg upside
12 analysts
|
— | +4.4% | · |
|
NRXS
NeurAxis, Inc.
|
May 11, 2026 | BUY |
Strong Buy
+19.9% avg upside
3 analysts
|
— | -22.7% | · |
|
MDWD
Mediwound
|
Apr 06, 2026 | BUY |
Strong Buy
+57.0% avg upside
13 analysts
|
— | -17.4% | · |
|
BLBD
Blue Bird
|
Nov 20, 2025 | BUY |
Strong Buy
+17.9% avg upside
11 analysts
|
— | +23.1% | · |
|
SMTC
Semtech
|
Nov 19, 2025 | BUY |
Strong Buy
+7.9% avg upside
24 analysts
|
— | +94.4% | · |
|
MXL
Maxlinear
|
Oct 20, 2025 | BUY |
Strong Buy
-1.9% avg upside
17 analysts
|
— | +380.9% | · |
|
OKLO
Oklo Inc
|
Oct 17, 2025 | HOLD |
Strong Buy
+125.2% avg upside
25 analysts
|
— | -73.9% | · |
|
LGND
Ligand Pharma
|
Oct 09, 2025 | BUY |
Strong Buy
-5.2% avg upside
15 analysts
|
— | +60.0% | · |
|
INOD
Innodata
|
Oct 08, 2025 | BUY |
Strong Buy
+99.5% avg upside
8 analysts
|
— | -31.5% | · |
|
KORU
Direxion MSCI Daily South Korea Bull 3X Shares
|
Aug 07, 2025 | BUY |
Strong Buy
1 analyst
|
— | · | · |
|
CDLX
Cardlytics
|
Jul 23, 2025 | HOLD |
Hold
+408.0% avg upside
16 analysts
|
— | · | · |
|
AEHR
Aehr Test Systems
|
Jul 22, 2025 | BUY |
Strong Buy
+14.3% avg upside
5 analysts
|
— | +365.4% | · |
|
NEXN
Nexxen International
|
Jul 14, 2025 | BUY |
Strong Buy
+26.1% avg upside
16 analysts
|
— | -0.1% | · |
|
TRLV
Trulieve Cannabis
|
Feb 26, 2025 | BUY |
Strong Buy
+131.7% avg upside
15 analysts
|
$11.50
19.10% Upside
|
+57.4% | · |
|
RMNI
Rimini Street
|
Feb 05, 2025 | BUY |
Strong Buy
+39.7% avg upside
9 analysts
|
— | +8.1% | · |
|
OMCL
Omnicell
|
Aug 28, 2024 | BUY |
Strong Buy
+36.5% avg upside
12 analysts
|
— | -26.4% | · |
|
ALKT
Alkami Technology
|
Aug 01, 2024 | BUY |
Strong Buy
+21.2% avg upside
16 analysts
|
$38.00
86.53% Upside
|
-39.5% | · |
|
SPIR
Spire Global
|
Jul 18, 2024 | BUY |
Buy
+17.0% avg upside
12 analysts
|
— | -11.0% | · |
|
OABI
OmniAb
|
Mar 21, 2024 | BUY |
Strong Buy
+104.8% avg upside
10 analysts
|
$10.00
159.10% Upside
|
-50.8% | · |
|
CSBR
Champions Oncology
|
Oct 16, 2023 | BUY |
Strong Buy
+66.0% avg upside
6 analysts
|
— | -27.7% | · |
|
ISPC
iSpecimen
|
Sep 13, 2023 | BUY |
Strong Buy
+81.5% avg upside
3 analysts
|
— | · | · |
|
FSLY
Fastly
|
Aug 18, 2023 | BUY |
Buy
+23.1% avg upside
26 analysts
|
— | -66.5% | · |
|
INFU
InfuSystem Holdings
|
May 04, 2023 | BUY |
Strong Buy
+30.7% avg upside
7 analysts
|
— | -11.3% | · |
|
ZG
Zillow Group Class A
|
May 03, 2023 | BUY |
Buy
+60.4% avg upside
46 analysts
|
$58.00
63.63% Upside
|
-3.4% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.